Related Articles
MITOXANTRONE, ETOPOSIDE AND BLEOMYCIN (MEB) CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA PATIENTS NON-ELEGIBLE FOR STANDARD CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE AND PREDNISONE (CHOP) COMBINATION
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer.
PHASE-I TRIAL OF THIOTEPA, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND PREDNISONE OR PENTOXIFYLLINE IN PATIENTS WITH REFRACTORY SOLID TUMORS
THE USE OF PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITORS MOBILIZED WITH STANDARD-DOSE CHEMOTHERAPY PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR TO SUPPORT MULTICYCLIC DOSE-INTENSIVE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER
A pilot study of paclitaxel and carboplatin for recurrent ovarian cancer